Announcements

    Drinks

      Scope publishes final rating methodology for Pharmaceutical Companies’ Rating Methodology
      FRIDAY, 05/04/2024 - Scope Ratings GmbH
      Download PDF

      Scope publishes final rating methodology for Pharmaceutical Companies’ Rating Methodology

      The methodology is now final following a call-for-comments period and will apply to all issuer and debt ratings of corporates in the sector. The application of the updated methodology will not trigger any rating changes.

      Scope Ratings GmbH (Scope) has today published its updated rating methodology for pharmaceutical companies. The update provides a detailed presentation of Scope’s analytical approach for assigning credit ratings to pharmaceutical companies. The application of this methodology will not trigger any rating changes.

      The updated methodology can be downloaded here.

      Besides editorial changes, with this update Scope

      • aligned the industry risk matrix with the General Corporate Rating Methodology;
         
      • provided extended guidance on the assessment of business risk profile, including the ‘CCC and below’ category for operating profitability;
         
      • regrouped and introduced business risk profile assessment tables for the generics segment. This involved repositioning the formerly used diversification table to market shares and introducing a new diversification table;
         
      • assigned an implicit, qualitative factor to the formerly and explicitly defined ‘other’ rating driver element in the business risk profile;
         
      • aligned the financial guidance table with the General Corporate Rating Methodology and provided values for a AAA assessment on all credit metrics.

      Scope invited market participants to comment on the methodology by 10 February 2024. Scope has not received comments from market participants. 

      Related news

      Show all
      Scope downgrades Nitrogénművek to B- and maintains Under Review status for a possible downgrade

      21/6/2024 Rating announcement

      Scope downgrades Nitrogénművek to B- and maintains Under ...

      Scope affirms B+/Stable rating of Pannon-Work Zrt.

      20/6/2024 Rating announcement

      Scope affirms B+/Stable rating of Pannon-Work Zrt.

      Scope affirms AEI’s issuer rating at B+ and maintains Negative Outlook.

      19/6/2024 Rating announcement

      Scope affirms AEI’s issuer rating at B+ and maintains ...

      Global economic update: soft landing reinforces prospect of higher-for-longer interest rates

      19/6/2024 Research

      Global economic update: soft landing reinforces prospect of ...

      Scope affirms Tine’s A-/Stable issuer rating

      19/6/2024 Rating announcement

      Scope affirms Tine’s A-/Stable issuer rating

      Scope affirms the B+/Stable issuer rating on Forrás Nyrt.

      18/6/2024 Rating announcement

      Scope affirms the B+/Stable issuer rating on Forrás Nyrt.